These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3552271)

  • 1. Toxicity, mutagenicity, intracellular drug concentration and DNA binding in Escherichia coli treated with cis-platinum(II) complexes.
    Razaka H; Wimmer F; Wimmer S; Villani G; Johnson NP
    Chem Biol Interact; 1987 Mar; 61(3):265-75. PubMed ID: 3552271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of an E. coli strain resistant to the toxic and mutagenic action of cis-diamminedichloroplatinum(II).
    Villani G; Lherisson C; Defais M; Johnson NP
    Mutat Res; 1987 Jan; 183(1):21-9. PubMed ID: 3540652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.
    Yarema KJ; Wilson JM; Lippard SJ; Essigmann JM
    J Mol Biol; 1994 Mar; 236(4):1034-48. PubMed ID: 8120885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity, mutagenicity and induction of recA protein in Escherichia coli treated with cis-diamminedichloroplatinum(II) and cis-diamminetetrachloroplatinum(IV).
    Razaka H; Salles B; Villani G; Johnson NP
    Chem Biol Interact; 1986 Nov; 60(2):207-15. PubMed ID: 3539376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the Escherichia coli UvrAB proteins to the DNA mono- and diadducts of cis-[N-2-amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II ) and cisplatin. Analysis of the factors controlling recognition and proof of monoadduct-mediated UvrB-DNA cross-linking.
    Lambert B; Jestin JL; Bréhin P; Oleykowski C; Yeung AT; Mailliet P; Prétot C; Le Pecq JB; Jacquemin-Sablon A; Chottard JC
    J Biol Chem; 1995 Sep; 270(36):21251-7. PubMed ID: 7673159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of Escherichia coli recF mutant strains for analyzing the genotoxicity of complex platinum compounds].
    Ptitsyn LR; Riazanova LA; Ivanov VB
    Genetika; 1997 Jul; 33(7):1020-4. PubMed ID: 9378282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum complexes with anticancer potential and their evaluation by a colorimetric lambda prophage induction assay.
    Das Sarma B; Daley SK; Elespuru RK
    Chem Biol Interact; 1983 Sep; 46(2):219-32. PubMed ID: 6226378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2].
    Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP
    Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors.
    Yoshida M; Khokhar AR; Zhang YP; Thai G; Siddik ZH
    Cancer Chemother Pharmacol; 1994; 35(1):38-44. PubMed ID: 7987975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin.
    Yoshida M; Khokhar AR; Kido Y; Ali-Osman F; Siddik ZH
    Biochem Pharmacol; 1994 Aug; 48(4):793-9. PubMed ID: 8080453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC; van Dijk M; Lohman PH
    Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced mutagenesis during post-treatment incubation of Escherichia coli treated with cis-diamminedichloroplatinum(II).
    Razaka H; Villani G; Hoffman JS; Defais M; Johnson NP
    Mutat Res; 1988; 209(1-2):63-6. PubMed ID: 3140004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
    Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new antitumor drug cycloplatam: cytotoxicity and DNA interstrand cross-linking].
    Gorbacheva LB; Vasil'eva SV; Makhova EV; Moshkovskaia EIu; Sokolova IS; Tikhomirov AG; Dederer LIu
    Antibiot Khimioter; 1999; 44(4):9-12. PubMed ID: 10483489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ; Barnard CF; Murrer BA; Kelland LR
    Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.